NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 4 மணி நேரத்திற்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Q2FY27 PAT Jumps 51.8% YoY to ₹80.8 Cr; Revenue Up 41.9% to ₹458.9 Cr
Manorama Industries released its Q2 & H1FY27 investor presentation, reporting consolidated Q2FY27 revenue of ₹458.9 Cr, up 41.9% YoY, driven by higher utilization of upgraded fractionation capacity and a stronger value-added mix. Consolidated PAT for the quarter rose 51.8% YoY to ₹80.8 Cr with PAT margin expanding 114 bps to 17.6%. For H1FY27, revenue reached ₹862.9 Cr (up 40.8% YoY) and PAT reached ₹159.5 Cr (up 59.2% YoY). Exports contributed 61% of H1FY27 revenue, while net debt-to-equity improved substantially to 0.04x as of September 30, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுCompany published detailed presentation of Q2 and H1FY27 financial performance and balance sheet position.
ஏன் இது முக்கியம்Demonstrates continued strong revenue and earnings expansion following capacity additions, alongside a de-leveraging balance sheet.
Q2FY27 Consolidated Revenue: ₹4,588.6 MnQ2FY27 Consolidated PAT: ₹808.1 MnH1FY27 Consolidated Revenue: ₹8,628.7 MnH1FY27 Revenue vs FY26 Full Year: ~63.1%Consolidated Net Debt to Equity: 0.04x
📅 குறுகிய காலம்Market sentiment should react favorably to the >50% YoY net profit growth and strong top-line momentum.
📈 நீண்ட காலம்Sustained capacity utilization towards 52,000 MT and geographic expansion via international subsidiaries could cement specialty fat leadership, subject to raw material availability.
⚠ அபாய எச்சரிக்கைகள்
Working capital cycle stretched to 233 days in H1FY27 from 123 days in FY26
Seasonality and geographic concentration risk in wild forest seed procurement (e.g., West Africa)
👀 கவனிக்க வேண்டியவை
Track capacity utilization levels at the upgraded fractionation plant and raw material sourcing stability in West Africa during peak collection seasons.
Manorama Industries Reshuffles Top Leadership; Appoints Deep Saraf as Managing Director for 5 Years
Manorama Industries has restructured its top leadership effective November 12, 2026. Ashish Ramesh Saraf resigned as Chairman and Managing Director, transitioning to President - Strategic Planning and Business Development, while Vinita Ashish Saraf stepped down as Vice Chairperson to become President - Business Excellence & Development. The Board appointed Deep Saraf as Managing Director for a 5-year term (November 12, 2026 to November 11, 2031) and Mudit Kumar Singh as Executive Director and Chairman of the Board. These leadership changes and remuneration approvals are subject to shareholder approval via postal ballot with a cut-off date of November 20, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுAshish Ramesh Saraf stepped down as CMD and Vinita Ashish Saraf as Vice Chairperson, handing over Board leadership to Deep Saraf (MD) and Mudit Kumar Singh (Chairman), while moving into senior management advisory/planning roles.
ஏன் இது முக்கியம்A transition in the core executive leadership at a company with ₹12,528 Cr market cap is significant for corporate governance and long-term execution, though retaining promoters in senior operational roles aims to ensure business continuity.
MD appointment tenure: 5 (Five) yearsTenure period: நவம்பர் 12, 2026 to நவம்பர் 11, 2031Postal ballot cut-off date: நவம்பர் 20, 2026TTM வருவாய்: ₹1,482 கோடிசந்தை மதிப்பு: ₹12,528 கோடி
📅 குறுகிய காலம்Market focus will be on the smooth handover of executive roles and shareholder e-voting on the postal ballot resolutions.
📈 நீண்ட காலம்Ensuring continuity of growth execution (scaling the 52,000 MT capacity and global expansion) under the new MD will be the primary structural metric to evaluate.
⚠ அபாய எச்சரிக்கைகள்
Key management transition risk at the Board level
Related-party remuneration approvals for former directors holding places of profit
👀 கவனிக்க வேண்டியவை
Track the outcome of the postal ballot voting for shareholder approval of the director appointments and executive remuneration, and monitor management commentary during upcoming investor interactions for strategic continuity.
India Ratings Upgrades Manorama Industries' Bank Loan Facilities to IND A+/Positive/IND A1+
Manorama Industries Limited has received a credit rating upgrade from India Ratings and Research for its bank loan facilities totaling Rs 496.77 crore (INR 4,967.70 million). The long-term and short-term ratings have been upgraded to IND A+/Positive and IND A1+, respectively. This upgrade reflects strengthening operational and financial performance, backed by TTM revenue of Rs 1,482 crore and a low D/E ratio of 0.51. The rated facilities represent approximately 71.5% of the company's net worth of Rs 695 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுIndia Ratings upgraded Manorama Industries' bank loan facilities to IND A+/Positive/IND A1+ from previous ratings.
ஏன் இது முக்கியம்The upgrade validates the company's balance sheet strength, lower leverage profile, and may help reduce debt servicing costs across its Rs 496.77 crore bank facilities.
Bank loan facilities size: INR 4,967.70 millionUpgraded Rating: IND A+/Positive/IND A1+Facility size vs TTM revenue: ~33.5%Facility size vs Net Worth: ~71.5%
📅 குறுகிய காலம்Positive sentiment driver in the immediate term reflecting credit profile enhancement.
📈 நீண்ட காலம்Enhances financial flexibility and reduces interest cost pressures as the company scales capacity towards its target utilization.
👀 கவனிக்க வேண்டியவை
Monitor upcoming quarterly results and management commentary on borrowing costs, as rating upgrades typically lower working capital interest spreads.
Manorama approves ₹75 Cr capital infusion across 6 overseas units and appoints Independent Director
Manorama Industries' Board approved a cumulative capital infusion of up to ₹75 Crore across six wholly-owned global subsidiaries in Ghana, Brazil, Burkina Faso, Nigeria, Chad, and the UAE. This capital deployment represents approximately 10.8% of the company's net worth (₹695 Cr) and aims to strengthen raw material sourcing and global operations. Additionally, the Board appointed Dr. Rohini Tiwari as a Non-Executive Independent Director for a 5-year term subject to postal ballot approval, while noting the tenure completion of Mr. Mudit Kumar Singh.
உச்சம் நம்பிக்கை
என்ன மாறியதுManorama approved infusing up to ₹75 Cr in equity capital into 6 international subsidiaries and inducted Dr. Rohini Tiwari to the Board as an Independent Director.
ஏன் இது முக்கியம்The ₹75 Cr capital infusion (10.8% of net worth) supports the company's stated strategy to secure forest-based raw materials from West Africa and expand reach across global confectionery and ethical beauty markets.
Total subsidiary capital infusion: ₹75.00 கோடிInfusion vs Net worth: ~10.8%Ghana subsidiary infusion: ₹20.00 கோடிBrazil & Burkina Faso infusions (each): ₹15.00 கோடிPostal ballot cut-off date: செப்டம்பர் 11, 2026
📅 குறுகிய காலம்Administrative approval process via postal ballot will conclude in the coming weeks; minimal immediate operational impact.
📈 நீண்ட காலம்Strengthens supply chain integration and raw material procurement across key African and South American sourcing corridors, mitigating sourcing risk.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical and operational risks in African jurisdictions (Burkina Faso, Chad, Nigeria, Ghana)
Execution risk in deploying capital efficiently across diverse overseas entities
👀 கவனிக்க வேண்டியவை
Monitor shareholder approval via the upcoming postal ballot and track subsequent progress on West African and Latin American sourcing capacity utilization in quarterly updates.
Manorama Ind Q1 FY27 Concall: PAT jumps 67.6% YoY to ₹79 Cr, Revenue reaches ₹404 Cr
Manorama Industries published its Q1 FY27 earnings conference call transcript, discussing strong operational momentum with quarterly revenue growing 39.5% YoY to ₹404 crore. EBITDA rose 42.2% YoY to ₹106 crore (margin at 26.3%), while PAT surged 67.6% YoY to ₹79 crore (margin at 19.5%). Management highlighted expansion initiatives, including acquiring ~10 hectares (24 acres) in Burkina Faso for shea/mango processing and establishing a subsidiary in Chad. Export to domestic revenue mix stood at 60:40, while other income included ₹13 crore of forex gains.
உச்சம் நம்பிக்கை
என்ன மாறியதுManorama Industries released the official verbatim transcript of its Q1 FY27 earnings conference call held on August 14, 2026.
ஏன் இது முக்கியம்Provides management commentary on sourcing integration in West Africa, margin sustainability, and utilization ramp-up of the expanded fractionation capacities.
Q1 FY27 Revenue: ₹404 கோடிQ1 FY27 PAT: ₹79 கோடிEBITDA லாப வரம்பு: 26.3%Burkina Faso Land Acquired: 10 hectares (24 acres)Forex Gain in Other Income: ₹13 கோடி
📅 குறுகிய காலம்Confirms strong quarterly financial trajectory and stable operating performance post recent QIP fundraise and capacity expansion.
📈 நீண்ட காலம்Backward integration into West African sourcing and capacity expansion in specialty fats should support long-term margins and market share gains in global cocoa butter alternatives.
⚠ அபாய எச்சரிக்கைகள்
Raw material seasonality and supply chain exposure to West Africa
₹13 Cr of Q1 PAT supported by forex gains included in other income
👀 கவனிக்க வேண்டியவை
Track execution and regulatory approvals for the Burkina Faso and Raipur processing facilities, alongside volume ramp-up from the 52,000 MT total capacity.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Manorama Industries has outlined a significant growth roadmap in its Q1FY27 presentation, following a strong FY26 where revenue reached ₹1,367 Cr with a 46.2% ROCE. The company has expanded its fractionation capacity to 47,500 MTPA as of Q1FY27 and is targeting 52,000 MTPA within the current fiscal year. A major ₹460 Cr capex plan (approx. 34% of TTM revenue) is proposed over the next 2-3 years to add a 75,000 TPA fractionation plant and a processing facility in Burkina Faso. The company maintains a high-efficiency model with a 7.4x asset turnover and a 60:40 export-domestic revenue mix.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from its previous capacity expansion phase (25,000 MTPA added in 2024) to a new ₹460 Cr investment cycle focused on global backward integration and a third fractionation plant.
ஏன் இது முக்கியம்The expansion targets the high-margin Cocoa Butter Equivalent (CBE) market where regulatory support (up to 5% usage in chocolate) and demand for sustainable cosmetic ingredients are driving growth.
📅 குறுகிய காலம்The market is likely to react positively to the high capital efficiency (ROCE) and the clear roadmap for tripling fractionation capacity compared to FY22 levels.
📈 நீண்ட காலம்Structural growth is supported by the shift toward value-added specialty fats and global sourcing hubs, potentially sustaining the 40% expected growth rate over the next 2-3 years.
⚠ அபாய எச்சரிக்கைகள்
Execution risk of large-scale capex
Raw material seasonality (15-20% supply risk)
Geopolitical risks in West African sourcing regions
👀 கவனிக்க வேண்டியவை
Watch for the board's final approval and execution timeline of the ₹460 Cr capex, specifically the commissioning of the Burkina Faso facility which is key for raw material security.
Manorama Industries delivered a robust Q1 FY27, with revenue increasing 39.5% YoY to Rs 404.01 Cr, surpassing the Rs 400 Cr quarterly milestone for the first time. Net profit surged 67.6% YoY to Rs 78.66 Cr, supported by a 326 bps expansion in PAT margins to 19.5%. The company is strengthening its global supply chain by acquiring 24 acres in Burkina Faso and establishing a new subsidiary in Chad for Shea sourcing. Export revenue remains the primary driver, contributing 60% of the total revenue mix.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company achieved its highest-ever quarterly revenue and significantly improved its bottom-line margins while expanding its physical sourcing footprint in West Africa.
ஏன் இது முக்கியம்The results validate the company's ability to scale its specialty fats business while maintaining high margins (26% EBITDA) and securing its raw material supply chain through backward integration.
📅 குறுகிய காலம்Positive market reaction is expected as the earnings significantly exceeded the previous year's run rate and margins showed sequential improvement.
📈 நீண்ட காலம்Structural growth remains strong as the company integrates its African supply chain and targets higher-value segments like ethical beauty and luxury products.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical risks in West African sourcing regions
Seasonality of forest-based raw material collection
Regulatory approvals pending for the Burkina Faso project
👀 கவனிக்க வேண்டியவை
Monitor the execution timeline for the Burkina Faso facility and the utilization levels of the 52,000 MT capacity, which management targets for Rs 1,800-2,000 Cr in annual revenue.
₹20.64 Cr voluntary customs duty payment by Manorama Industries following UAE import inquiry
Manorama Industries has voluntarily deposited ₹20.64 Cr with Customs authorities following an inquiry into preferential tariff claims under the India-UAE CEPA. The inquiry, initiated by the Special Intelligence & Investigation Branch (SIB) Indore, concerns the eligibility of Palm Mid Fraction imports for lower duties. The company has paid the full differential duty, interest, and penalties to avoid further litigation while issuing a debit note to its UAE supplier to recover the amount. This one-time payment represents approximately 9.8% of the company's TTM PAT and 3% of its Net Worth.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from a preferential tariff regime to paying full customs duty for specific past imports and has initiated a legal recovery process against its overseas supplier.
ஏன் இது முக்கியம்The ₹20.64 Cr outflow is a material one-time hit to liquidity and earnings, representing nearly 10% of annual profits, and highlights compliance risks in international sourcing.
Total Voluntary Deposit: ₹20.64 கோடிDeposit vs TTM PAT: ~9.8%Deposit vs Net Worth: ~3.0%Differential Customs Duty: ₹16.95 கோடிPenalty Component: ₹1.03 கோடி
📅 குறுகிய காலம்The stock may face minor pressure due to the one-time cash outflow and the disclosure of a regulatory inquiry, though the voluntary nature of the payment reduces litigation uncertainty.
📈 நீண்ட காலம்Limited structural impact if the company successfully recovers the amount from the supplier or adjusts its sourcing documentation to comply with CEPA requirements.
⚠ அபாய எச்சரிக்கைகள்
Regulatory scrutiny
Supplier dispute
One-time earnings hit
Potential loss of preferential tariff benefits
👀 கவனிக்க வேண்டியவை
Monitor the success of the recovery action against the UAE supplier and check for any impact on gross margins in upcoming quarters if preferential tariff benefits are permanently discontinued for these imports.
Manorama Industries Incorporates New Subsidiary in Republic of Chad with CFA 1 Cr Capital
Manorama Industries has incorporated a wholly-owned subsidiary, Manorama Savannah Agro Chad SARL, in the Republic of Chad on July 20, 2026. The new entity has an authorized and paid-up capital of CFA 10,000,000 (approximately ₹13.7 Lakhs) and will focus on trading in the food and cosmetic industries. This move aligns with the company's strategy to leverage global subsidiaries for sourcing and market expansion in West Africa. While the initial investment is small, it supports the company's goal of reaching 100% utilization of its 52,000 MT capacity.
உச்சம் நம்பிக்கை
என்ன மாறியதுManorama Industries has established a direct legal presence in the Republic of Chad through a new wholly-owned subsidiary.
ஏன் இது முக்கியம்Direct presence in West Africa is crucial for securing forest-based raw materials like Shea, reducing supply chain risks and supporting the utilization of the company's 52,000 MT fractionation capacity.
📅 குறுகிய காலம்Minimal immediate impact on stock price as the capital investment is small relative to the company's ₹9,558 Cr market cap.
📈 நீண்ட காலம்Strategically significant for securing the supply chain in a key sourcing region, which is essential for long-term margin stability and growth in the specialty fats segment.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical risks in the Republic of Chad
Sourcing disruptions in West Africa
👀 கவனிக்க வேண்டியவை
Monitor how this subsidiary improves raw material sourcing efficiency from West Africa, which is a critical factor for maintaining the company's 25.3% operating margins.
Manorama to incorporate Wholly Owned Subsidiary in Chad with CFA 1 Cr capital
Manorama Industries has approved the incorporation of a new wholly-owned subsidiary (WOS) in Chad, named Manorama Savannah Agro Chad SARL. The entity will focus on the procurement, processing, and sale of shea nuts and butter, which are critical raw materials for the company's specialty fats business. With an initial capital of CFA 1,00,00,000 (approximately ₹13.7 Lakhs), the investment is small relative to the company's ₹9,054 Cr market cap but strategically significant. This move aligns with the company's goal to secure its supply chain in West Africa and support its target of reaching ₹1,150 Cr+ revenue in FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுManorama is formalizing its presence in Chad by establishing a dedicated legal entity for raw material sourcing and processing.
ஏன் இது முக்கியம்Direct presence in West Africa is crucial for securing shea nuts, a key ingredient for their high-margin specialty fats and 'Ethical Beauty' segments, reducing reliance on third-party sourcing.
📅 குறுகிய காலம்The announcement is likely to be viewed positively as a sign of strategic execution, though the immediate financial impact is negligible due to the small initial capital.
📈 நீண்ட காலம்Structurally positive as it strengthens backward integration and supply chain resilience in a key sourcing region, supporting the company's 40% expected growth rate.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical and regulatory risks in Chad
Execution risk in setting up processing infrastructure
Seasonality of forest-based raw material collection
👀 கவனிக்க வேண்டியவை
Monitor the operational timeline for the Chad facility and its impact on raw material sourcing costs, particularly how it mitigates the 15-20% supply reduction typically seen in off-peak quarters.
₹500 Cr QIP Allotment Completed at ₹1,470 per Share
Manorama Industries has successfully completed a ₹500 crore Qualified Institutions Placement (QIP), allotting 34.01 lakh shares to institutional investors. The issue price of ₹1,470 per share includes a 4.99% discount to the floor price. This capital infusion is highly material, representing approximately 72% of the company's existing net worth of ₹695 crore and about 5.3% of its current market capitalization. High-profile allottees include ValueQuest funds (35% combined), Abu Dhabi Investment Authority (6.44%), and WhiteOak Capital.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully raised ₹500 crore in fresh equity capital, increasing its paid-up share capital from ₹11.94 crore to ₹12.62 crore.
ஏன் இது முக்கியம்This massive capital infusion significantly strengthens the balance sheet, providing the necessary liquidity to fund aggressive capacity utilization and global expansion targets without increasing debt levels.
Total Fundraise: ₹500 கோடிFundraise vs Net Worth: ~72%Issue Price: ₹1,470Equity Dilution: ~5.4%Discount to Floor Price: 4.99%
📅 குறுகிய காலம்The successful pricing and participation by marquee institutional investors like ADIA and Goldman Sachs are likely to be viewed positively by the market in the coming weeks.
📈 நீண்ட காலம்The capital supports the company's structural growth plan to leverage its 52,000 MT capacity and expand into luxury cosmetic segments, potentially re-rating the business if execution targets are met.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of ~5.4%
Execution risk in deploying large capital efficiently to maintain high ROCE
👀 கவனிக்க வேண்டியவை
Investors should monitor the deployment of these funds toward the company's stated goal of scaling revenue to ₹1,150 Cr+ in FY26 and expanding into high-margin ethical beauty segments.
₹500 Cr QIP Closure: Manorama Industries Allocates 34.01 Lakh Shares at ₹1,470 Each
Manorama Industries has successfully closed its Qualified Institutions Placement (QIP), raising approximately ₹500 crore. The company allocated 34,01,360 equity shares at an issue price of ₹1,470 per share, which includes a 4.99% discount to the floor price. This capital infusion is highly material, representing approximately 72% of the company's current net worth (₹695 Cr) and will result in an equity dilution of roughly 5.7%. The funds are expected to support the company's target of scaling revenue to ₹1,150 Cr+ in FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has completed a major institutional fundraise, significantly strengthening its cash position and equity base.
ஏன் இது முக்கியம்This provides the necessary capital to fuel the company's 40% growth guidance and expansion into luxury segments without increasing its debt-to-equity ratio (currently 0.51).
Total Fundraise Amount: ₹500 கோடிIssue Price: ₹1,470Fundraise vs Net Worth: ~72%Shares Allocated: 34,01,360Discount to Floor Price: 4.99%
📅 குறுகிய காலம்The successful institutional interest and capital infusion are likely to be viewed positively by the market, though the 5% discount to the floor price may lead to short-term price alignment.
📈 நீண்ட காலம்The capital significantly de-risks the company's expansion plans and provides the liquidity needed to scale operations toward its ₹1,800-2,000 Cr revenue potential at full capacity utilization.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of approximately 5.7%
Execution risk in deploying large capital to meet high growth targets
👀 கவனிக்க வேண்டியவை
Investors should monitor the deployment of these funds toward the 52,000 MT capacity utilization and the expansion into high-margin 'Ethical Beauty' segments as guided by management.
Manorama Industries has officially launched its Qualified Institutions Placement (QIP) on June 29, 2026. The board has set the floor price at ₹1,547.18 per share, which is a 3.97% discount to the current market price of ₹1,611.2. The company has the discretion to offer an additional discount of up to 5% to institutional investors. This capital raise follows a shareholder approval from April 2026 and is aimed at supporting the company's aggressive growth targets, including a revenue goal of ₹1,150 Cr+ for FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from the approval phase to the execution phase of its institutional fundraise (QIP).
ஏன் இது முக்கியம்The fundraise will provide the necessary capital to scale operations toward the company's ₹1,800-2,000 Cr revenue potential at full capacity utilization, while potentially impacting the current debt-to-equity ratio of 0.51.
📅 குறுகிய காலம்The stock price may experience volatility and potentially align closer to the final QIP allotment price over the coming weeks.
📈 நீண்ட காலம்If successfully deployed into high-margin 'Ethical Beauty' and luxury segments, this capital could support the management's 40% expected growth rate and high ROCE (currently 35%).
⚠ அபாய எச்சரிக்கைகள்
Equity dilution for existing shareholders
Utilization of proceeds risk
Market volatility during the issue period
👀 கவனிக்க வேண்டியவை
Investors should watch for the final issue price and the total amount of capital raised to calculate the exact equity dilution. Monitor subsequent filings for the specific allocation of funds toward the 52,000 MT capacity utilization or new product segments.
Manorama Industries FY26 Revenue Surges 76.1% to ₹1,358 Cr; PAT at ₹233.2 Cr
Manorama Industries delivered exceptional FY26 performance with revenue growing 76.1% YoY to INR 1,358 crores, driven by strong volume growth in specialty fats. The company maintained high profitability with an EBITDA margin of 27.1% and reported a PAT of INR 233.2 crores. Operational efficiency improved as the working capital cycle reduced to 125 days from 151 days, resulting in a strong operating cash flow of INR 259.4 crores. Management outlined a strategic capex plan of INR 460 crores over the next 2-3 years to expand capacity and integrate backward in West Africa.
முக்கிய அம்சங்கள்
FY26 Revenue increased 76.1% YoY to INR 1,358 crores with a PAT margin of 17.2%.EBITDA for the full year stood at INR 367.7 crores with a healthy margin of 27.1%.Return on Equity (ROE) and Return on Capital Employed (ROCE) reached 40.3% and 33.6% respectively.Announced INR 460 crore capex for a new fractionation facility, refinery expansion, and a Burkina Faso processing unit.Working capital cycle improved significantly to 125 days, boosting net cash flow from operations to INR 259.4 crores.
👀 கவனிக்க வேண்டியவை
Investors should maintain a positive outlook given the company's robust growth trajectory, high return ratios, and clear expansion roadmap. Monitor the execution of the Burkina Faso project as it is expected to further optimize logistics costs and margins.
Manorama Industries FY26 PAT Surges 108.1% to INR 2,332 Mn; Proposes Final Dividend
Manorama Industries delivered an exceptional performance for FY26, with revenue increasing by 76.1% YoY to INR 13,577 Mn, driven by a favorable product mix and higher capacity utilization. EBITDA grew 92.5% YoY to INR 3,677 Mn, with margins expanding by 230 bps to 27.1%. Net profit (PAT) surged by 108.1% YoY to INR 2,332 Mn, reflecting high capital efficiency as annual cash profit exceeded its gross block. The company also announced a strategic capex plan of INR 460 crores over the next 2-3 years and a final dividend of INR 0.80 per share.
முக்கிய அம்சங்கள்
FY26 Revenue grew 76.1% YoY to INR 13,577.0 Mn, with a Domestic to Export mix of 43:57.FY26 EBITDA increased by 92.5% YoY to INR 3,677.1 Mn; EBITDA margin expanded by 230 bps to 27.1%.FY26 PAT surged 108.1% YoY to INR 2,332.2 Mn, though Q4 FY26 PAT fell 12.8% QoQ due to foreign exchange provisions.Planned strategic capex of approximately INR 460 crores over the next 2-3 years for forward/backward integration and global expansion.Board recommended a final dividend of INR 0.80 per equity share (40% of face value of INR 2).
👀 கவனிக்க வேண்டியவை
Investors should view this as a highly positive earnings report demonstrating robust growth and strong capital efficiency. The planned INR 460 crore capex provides strong visibility for future growth, though short-term currency fluctuations should be monitored.
Manorama Industries has recommended a final dividend of ₹0.80 per share for FY26, representing 40% of the face value. The company is undertaking a major international expansion by setting up a processing factory in Burkina Faso through its subsidiary, Taang Kaam Industries SA. To support this, the board has approved a total financial package of up to ₹350 Crore, including equity, loans, and guarantees. Additionally, the company corrected a clerical error in its previously filed FY26 audited results, which received a clean audit opinion.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹0.80 per equity share (40% of ₹2 face value) for FY 2025-26.Approved equity investment of up to ₹150 Crore in subsidiary Taang Kaam Industries SA for a new factory.Authorized additional financial support of up to ₹200 Crore through unsecured loans and corporate guarantees.Statutory auditors issued an unmodified (unqualified) opinion for the FY26 financial results.Re-appointed CLA Indus Value Consulting and M/s. S N & Co. as internal and cost auditors for FY 2026-27.
👀 கவனிக்க வேண்டியவை
The significant capital commitment for the Burkina Faso project signals aggressive growth plans; investors should monitor the execution timeline and potential impact on debt levels.
Manorama Industries reported a robust 76.1% YoY revenue growth to ₹1,358 Crores for FY26, driven by strong demand in the food and cosmetics sectors. The company achieved a significant milestone with annual cash profit of ₹258.77 Crore, which now exceeds its gross block of ₹250.85 Crore, indicating high capital efficiency. A strategic capex of ₹460 Crores is planned over the next 2-3 years for expansion, including a new manufacturing facility and a processing plant in Burkina Faso. The Board recommended a final dividend of ₹0.80 per share while reporting an improved working capital cycle of 125 days.
முக்கிய அம்சங்கள்
Revenue grew 76.1% YoY to ₹1,358 Crores in FY26Cash profit of ₹258.77 Crore surpassed the total Gross Block of ₹250.85 CrorePlanned strategic capex of ₹460 Crores for capacity expansion and global integrationWorking capital cycle improved to 125 days with operating cash flow of ₹259 CroresSF 2 capacity increased by 30% to 32,500 TPA via debottlenecking
👀 கவனிக்க வேண்டியவை
Investors should favor the company's high capital efficiency and aggressive growth roadmap in specialty fats. Monitor the execution of the ₹460 Cr capex and its impact on future margins.
Manorama Industries FY26 PAT Surges 108% to ₹233 Cr; Announces ₹460 Cr Capex Plan
Manorama Industries delivered a stellar FY26 performance with revenue growing 76.1% YoY to INR 13,577 Mn and PAT doubling to INR 2,332.2 Mn. The company achieved significant margin expansion, with EBITDA margins rising 230 bps to 27.1% driven by a better product mix and higher capacity utilization. A final dividend of INR 0.80 per share was declared, and the company outlined a robust INR 460 crore capex plan for the next 2-3 years to fuel future growth. Operational efficiency was highlighted by cash profits exceeding the gross block, indicating high capital efficiency.
முக்கிய அம்சங்கள்
FY26 PAT surged 108.1% YoY to INR 2,332.2 Mn, while Revenue grew 76.1% to INR 13,577.0 MnEBITDA margins expanded by 230 bps YoY to 27.1% for the full year FY26Announced a strategic capex of ~INR 460 crores over 2-3 years for backward integration and global expansionIncreased SF 2 plant capacity by 30% to 32,500 TPA and improved working capital cycle to 125 daysBoard recommended a final dividend of INR 0.80 per equity share (40% of face value)
👀 கவனிக்க வேண்டியவை
Investors should view the strong earnings growth and high capital efficiency as positive indicators of the company's niche market leadership. The planned capex and capacity expansions suggest a strong growth runway, though monitoring the execution of the Burkina Faso plant and forex volatility is advised.
Manorama Industries Shareholders Approve INR 500 Crore Fundraise via QIP
Shareholders of Manorama Industries have approved a special resolution to raise up to INR 500 crore through Qualified Institutions Placement (QIP) or other permissible modes. The proposal received overwhelming support with 99.82% of votes cast in favor. This capital infusion is expected to fuel the company's growth initiatives and expansion plans. The resolution was officially passed following the conclusion of the postal ballot e-voting on April 19, 2026.
முக்கிய அம்சங்கள்
Approved fundraise of up to INR 500 crore in one or more tranches via QIP or other securities.Special resolution passed with a significant majority of 99.82% (4,11,77,725 votes) in favor.Only 0.17% of votes (72,928 shares) were cast against the proposal.Promoter and Promoter Group showed 100% support for the resolution with 3,24,33,406 votes.
👀 கவனிக்க வேண்டியவை
Investors should monitor the timing and pricing of the potential QIP, as it will indicate the level of institutional interest and the extent of equity dilution. The strong mandate reflects high shareholder confidence in the company's capital allocation plans.
Manorama Industries Credit Rating Upgraded to CARE A+; Stable for Rs 577.90 Cr Facilities
Care Edge Ratings has upgraded the credit rating for Manorama Industries Limited's long-term bank facilities to CARE A+; Stable from CARE A; Stable. The facility limit has been enhanced to Rs 577.90 Crore from Rs 492.90 Crore. Furthermore, the short-term rating for Rs 105 Crore of facilities was upgraded to CARE A1+ from CARE A1. This upgrade indicates a stronger financial profile and improved ability to service debt, which is a positive sign for long-term stakeholders.
முக்கிய அம்சங்கள்
Long-term rating upgraded to CARE A+; Stable for facilities worth Rs 577.90 Crore.Short-term rating upgraded to CARE A1+ for facilities worth Rs 105.00 Crore.Total long-term facility limit increased by Rs 85 Crore to Rs 577.90 Crore.Short-term facility limit significantly expanded from Rs 10 Crore to Rs 105 Crore.
👀 கவனிக்க வேண்டியவை
This upgrade validates the company's improving financial health and may lead to reduced borrowing costs. Investors should maintain a positive outlook on the stock's stability.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
